Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar

Proceedings From the First International Workshop at Sidra Medicine: “Engineered Immune Cells in Cancer Immunotherapy (EICCI): From Discovery to Off-the-Shelf Development”, 15th–16th February 2019, Doha, Qatar

The progress in the isolation and characterization of tumor antigen (TA)-specific T lymphocytes and in the genetic modification of immune cells allowed the clinical development of adoptive cell therapy (ACT). Several clinical studies highlighted the striking clinical activity of T cells engineered t...

Full description

Bibliographic Details
Main Authors: Bella Guerrouahen, Muhammad Elnaggar, Anjud Al-Mohannadi, Dhanya Kizhakayil, Chiara Bonini, Reuben Benjamin, Renier Brentjens, Christian J. Buchholz, Giulia Casorati, Soldano Ferrone, Frederick L. Locke, Francisco Martin, Axel Schambach, Cameron Turtle, Paul Veys, Hans J. van der Vliet, Cristina Maccalli, The EICCI Faculty Group
Format: Article
Language:English
Published: Frontiers Media S.A. 2021-01-01
Series:Frontiers in Immunology
Subjects:
cancer
immunotherapy
CAR-T cells
TCR engineered lymphocytes
CAR-NK cells
monoclonal antibody
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2020.589381/full

Internet

https://www.frontiersin.org/articles/10.3389/fimmu.2020.589381/full

Similar Items